Loading...
XSHG603976
Market cap338mUSD
Jan 02, Last price  
16.32CNY
1D
0.74%
1Q
0.74%
IPO
0.74%
Name

CHONGQING ZHENGCHUAN PHARMAC PCKG CO LTD

Chart & Performance

D1W1MN
XSHG:603976 chart
P/E
61.28
P/S
2.74
EPS
0.27
Div Yield, %
0.54%
Shrs. gr., 5y
-0.18%
Rev. gr., 5y
8.62%
Revenues
901m
+13.12%
405,801,648436,034,295479,683,554469,994,516508,681,599595,781,310521,080,827501,981,691796,657,258796,198,292900,648,636
Net income
40m
-37.83%
54,738,85468,913,13760,698,98270,511,32682,178,38782,766,62861,056,66653,050,474106,603,63564,770,59740,267,655
CFO
194m
+405.37%
076,862,58914,204,22125,717,77552,499,86064,296,75055,273,077121,794,840104,966,81938,426,207194,196,180
Dividend
Sep 25, 20240.1 CNY/sh
Earnings
May 23, 2025

Profile

ChongQing Zhengchuan Pharmaceutical Packaging Co.,Ltd. engages in the research and development, manufacturing, and selling of pharmaceutical glass packaging materials in China. It offers medium borosilicate glass ampoule bottles, medium borosilicate glass tube injection bottles, low borosilicate tubular vials and ampoules, oral liquid vials, screw neck vials, and plastic flip off and aluminum caps, as well as borosilicate glass and soda lime glass control bottles. The company was founded in 1988 and is headquartered in Chongqing, China.
URL
http://www.cqzcjt.com/
IPO date
Aug 22, 2017
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
900,649
13.12%
796,198
-0.06%
Cost of revenue
805,809
671,082
Unusual Expense (Income)
NOPBT
94,839
125,116
NOPBT Margin
10.53%
15.71%
Operating Taxes
4,559
Tax Rate
4.81%
NOPAT
90,280
125,116
Net income
40,268
-37.83%
64,771
-39.24%
Dividends
(13,325)
(46,570)
Dividend yield
0.45%
1.50%
Proceeds from repurchase of equity
BB yield
Debt
Debt current
30,000
60,370
Long-term debt
416,379
400,337
Deferred revenue
28,632
Other long-term liabilities
31,608
1
Net debt
258,707
89,216
Cash flow
Cash from operating activities
194,196
38,426
CAPEX
(89,972)
Cash from investing activities
(176,754)
Cash from financing activities
(43,645)
FCF
103,391
(233,509)
Balance
Cash
437,734
371,492
Long term investments
(250,062)
Excess cash
142,639
331,682
Stockholders' equity
659,884
628,569
Invested Capital
1,550,800
1,339,209
ROIC
6.25%
10.68%
ROCE
5.60%
7.46%
EV
Common stock shares outstanding
149,139
151,202
Price
19.71
-4.09%
20.55
-39.77%
Market cap
2,939,539
-5.40%
3,107,199
-39.77%
EV
3,198,246
3,196,415
EBITDA
201,913
211,579
EV/EBITDA
15.84
15.11
Interest
21,297
19,607
Interest/NOPBT
22.46%
15.67%